Expected value of information and decision making in HTA.

@article{Eckermann2007ExpectedVO,
  title={Expected value of information and decision making in HTA.},
  author={Simon Eckermann and Andrew R. Willan},
  journal={Health economics},
  year={2007},
  volume={16 2},
  pages={
          195-209
        }
}
  • Simon Eckermann, Andrew R. Willan
  • Published 2007
  • Economics, Medicine
  • Health economics
  • Decision makers within a jurisdiction facing evidence of positive but uncertain incremental net benefit of a new health care intervention have viable options where no further evidence is anticipated to:(1)adopt the new intervention without further evidence;(2)adopt the new intervention and undertake a trial; or(3)delay the decision and undertake a trial.Value of information methods have been shown previously to allow optimal design of clinical trials in comparing option (2) against option (1… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 121 CITATIONS, ESTIMATED 82% COVERAGE

    The Option Value of Delay in Health Technology Assessment

    VIEW 6 EXCERPTS
    CITES BACKGROUND

    Expected Net Present Value of Sample Information

    Globally optimal trial design for local decision making.

    VIEW 8 EXCERPTS
    CITES BACKGROUND & METHODS

    Value of Information and Pricing New Healthcare Interventions

    VIEW 9 EXCERPTS
    CITES BACKGROUND

    Enhancing value of information analyses.

    FILTER CITATIONS BY YEAR

    2007
    2020

    CITATION STATISTICS

    • 11 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 11 REFERENCES

    The Option Value of Delay in Health Technology Assessment

    VIEW 4 EXCERPTS

    The value of information and optimal clinical trial design.

    VIEW 4 EXCERPTS

    Irreversibility, Uncertainty and Cyclical Investment

    • BS Bernanke
    • Quarterly Journal of Economics
    • 1983

    Pilot study of using value of information analysis to set priorities in research and development

    • K Claxton, L Ginnelly, M Sculpher, S Palmer, Z. Philips
    • Health Technology Assessment,
    • 2004
    VIEW 1 EXCERPT